A detailed history of Acadian Asset Management LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Acadian Asset Management LLC holds 186,245 shares of ZTS stock, worth $30.4 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
186,245
Previous 174,788 6.55%
Holding current value
$30.4 Million
Previous $30.3 Million 20.09%
% of portfolio
0.11%
Previous 0.09%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$172.58 - $196.48 $1.98 Million - $2.25 Million
11,457 Added 6.55%
186,245 $36.4 Million
Q2 2024

Aug 06, 2024

BUY
$145.54 - $178.83 $21.8 Million - $26.8 Million
149,737 Added 597.73%
174,788 $30.3 Million
Q1 2024

May 10, 2024

BUY
$165.67 - $199.94 $1.38 Million - $1.66 Million
8,302 Added 49.57%
25,051 $4.24 Million
Q4 2023

Feb 13, 2024

SELL
$151.44 - $200.09 $156,588 - $206,893
-1,034 Reduced 5.81%
16,749 $3.3 Million
Q3 2023

Nov 13, 2023

BUY
$167.14 - $192.77 $1.65 Million - $1.9 Million
9,847 Added 124.08%
17,783 $3.09 Million
Q2 2023

Aug 07, 2023

SELL
$160.94 - $186.23 $1.66 Million - $1.92 Million
-10,292 Reduced 56.46%
7,936 $1.37 Million
Q1 2023

May 11, 2023

SELL
$145.48 - $175.02 $8.45 Million - $10.2 Million
-58,116 Reduced 76.12%
18,228 $3.03 Million
Q4 2022

Feb 14, 2023

SELL
$131.14 - $157.47 $2.58 Million - $3.1 Million
-19,705 Reduced 20.52%
76,344 $11.2 Million
Q3 2022

Nov 14, 2022

BUY
$148.29 - $182.55 $5.63 Million - $6.93 Million
37,983 Added 65.41%
96,049 $14.2 Million
Q3 2022

Nov 14, 2022

BUY
$148.29 - $182.55 $5.63 Million - $6.93 Million
37,983 Added 65.41%
96,049 $14.2 Million
Q2 2022

Aug 09, 2022

SELL
$155.97 - $200.09 $2.96 Million - $3.8 Million
-18,969 Reduced 24.62%
58,066 $9.98 Million
Q1 2022

May 12, 2022

SELL
$181.39 - $234.03 $1.9 Million - $2.46 Million
-10,500 Reduced 12.0%
77,035 $14.5 Million
Q4 2021

Feb 10, 2022

SELL
$193.69 - $247.03 $6.8 Million - $8.67 Million
-35,098 Reduced 28.62%
87,535 $21.4 Million
Q3 2021

Nov 12, 2021

BUY
$189.29 - $209.69 $4.85 Million - $5.37 Million
25,610 Added 26.4%
122,633 $23.8 Million
Q2 2021

Aug 11, 2021

SELL
$155.9 - $187.99 $2.63 Million - $3.17 Million
-16,889 Reduced 14.83%
97,023 $18.1 Million
Q1 2021

May 11, 2021

BUY
$144.0 - $169.39 $7.85 Million - $9.24 Million
54,525 Added 91.81%
113,912 $17.9 Million
Q4 2020

Feb 11, 2021

BUY
$157.07 - $174.35 $2.95 Million - $3.27 Million
18,758 Added 46.17%
59,387 $9.83 Million
Q3 2020

Nov 09, 2020

BUY
$137.1 - $165.37 $1.31 Million - $1.59 Million
9,585 Added 30.88%
40,629 $6.72 Million
Q2 2020

Aug 12, 2020

BUY
$111.92 - $142.53 $232,010 - $295,464
2,073 Added 7.16%
31,044 $4.25 Million
Q1 2020

May 11, 2020

BUY
$92.66 - $144.94 $2.68 Million - $4.2 Million
28,971 New
28,971 $3.41 Million
Q3 2019

Nov 07, 2019

SELL
$112.57 - $128.43 $134 Million - $153 Million
-1,189,740 Closed
0 $0
Q2 2019

Aug 08, 2019

SELL
$97.98 - $114.28 $51.1 Million - $59.6 Million
-521,595 Reduced 30.48%
1,189,740 $135 Million
Q1 2019

May 09, 2019

SELL
$81.56 - $100.67 $35 Million - $43.2 Million
-429,428 Reduced 20.06%
1,711,335 $172 Million
Q4 2018

Feb 07, 2019

SELL
$79.28 - $95.27 $6.54 Million - $7.85 Million
-82,439 Reduced 3.71%
2,140,763 $183 Million
Q3 2018

Oct 30, 2018

SELL
$83.5 - $93.23 $9.44 Million - $10.5 Million
-113,051 Reduced 4.84%
2,223,202 $204 Million
Q2 2018

Jul 24, 2018

BUY
$79.9 - $89.2 $11 Million - $12.3 Million
138,225 Added 6.29%
2,336,253 $199 Million
Q1 2018

Apr 12, 2018

BUY
$71.51 - $84.69 $34.9 Million - $41.4 Million
488,676 Added 28.59%
2,198,028 $184 Million
Q4 2017

Jan 18, 2018

BUY
$63.24 - $72.8 $56.9 Million - $65.5 Million
900,261 Added 111.27%
1,709,352 $123 Million
Q3 2017

Oct 13, 2017

BUY
$59.73 - $65.4 $48.3 Million - $52.9 Million
809,091
809,091 $51.6 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $76.5B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.